Waldencast plc (NASDAQ:WALD - Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $5.00 and last traded at $5.00, with a volume of 1539 shares trading hands. The stock had previously closed at $5.07.
Wall Street Analysts Forecast Growth
Separately, Telsey Advisory Group dropped their price objective on shares of Waldencast from $12.00 to $10.00 and set an "outperform" rating for the company in a report on Friday, March 22nd.
View Our Latest Research Report on Waldencast
Waldencast Stock Performance
The business has a 50-day simple moving average of $6.38 and a 200-day simple moving average of $8.15.
Institutional Trading of Waldencast
A number of institutional investors have recently modified their holdings of the company. Amalgamated Bank raised its position in Waldencast by 68.1% during the third quarter. Amalgamated Bank now owns 3,277 shares of the company's stock worth $31,000 after acquiring an additional 1,328 shares during the period. Barclays PLC grew its position in shares of Waldencast by 75.3% during the third quarter. Barclays PLC now owns 7,177 shares of the company's stock worth $67,000 after acquiring an additional 3,084 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Waldencast by 23.2% during the fourth quarter. SG Americas Securities LLC now owns 19,705 shares of the company's stock worth $216,000 after purchasing an additional 3,716 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in Waldencast by 44.4% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,226 shares of the company's stock worth $178,000 after purchasing an additional 4,992 shares during the period. Finally, State Board of Administration of Florida Retirement System purchased a new position in shares of Waldencast in the 3rd quarter valued at about $97,000. 41.97% of the stock is currently owned by institutional investors.
Waldencast Company Profile
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
